Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:DVAX
NasdaqGS:DVAXBiotechs

Should Dynavax Technologies' (DVAX) $100 Million Buyback and Guidance Update Prompt a Reassessment by Investors?

Dynavax Technologies Corporation recently announced a US$100 million share repurchase program, reported its third quarter 2025 earnings, and reiterated full-year net product revenue guidance for HEPLISAV-B of US$315 million to US$325 million. This series of updates highlights both management’s ongoing confidence in the core hepatitis B franchise and a renewed emphasis on capital returns to shareholders. Let’s explore how the newly announced share repurchase program may influence Dynavax's...